Teleflex Inc
NYSE:TFX

Watchlist Manager
Teleflex Inc Logo
Teleflex Inc
NYSE:TFX
Watchlist
Price: 180.14 USD 1.62% Market Closed
Market Cap: 8.4B USD
Have any thoughts about
Teleflex Inc?
Write Note

Teleflex Inc
Free Cash Flow

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Teleflex Inc
Free Cash Flow Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Free Cash Flow CAGR 3Y CAGR 5Y CAGR 10Y
Teleflex Inc
NYSE:TFX
Free Cash Flow
$450m
CAGR 3-Years
-7%
CAGR 5-Years
7%
CAGR 10-Years
6%
Becton Dickinson and Co
NYSE:BDX
Free Cash Flow
$3.1B
CAGR 3-Years
-4%
CAGR 5-Years
5%
CAGR 10-Years
11%
Boston Scientific Corp
NYSE:BSX
Free Cash Flow
$2.2B
CAGR 3-Years
12%
CAGR 5-Years
28%
CAGR 10-Years
10%
Stryker Corp
NYSE:SYK
Free Cash Flow
$3.2B
CAGR 3-Years
2%
CAGR 5-Years
11%
CAGR 10-Years
8%
Abbott Laboratories
NYSE:ABT
Free Cash Flow
$6.5B
CAGR 3-Years
-11%
CAGR 5-Years
11%
CAGR 10-Years
8%
Intuitive Surgical Inc
NASDAQ:ISRG
Free Cash Flow
$586m
CAGR 3-Years
-32%
CAGR 5-Years
-11%
CAGR 10-Years
-1%
No Stocks Found

Teleflex Inc
Glance View

Market Cap
8.4B USD
Industry
Health Care
Economic Moat
None

In the world of medical technology, Teleflex Inc. emerges as a nuanced, multifaceted player, crafting a narrative not just of survival, but of steady growth through innovation and strategic vision. Founded in the allure of post-war optimism in 1943, Teleflex began its journey in the aerospace and marine industries. However, recognizing the steadily aging global population and increasing healthcare demands, the company pivoted towards the medical sector, a decision that has since defined its contemporary identity. Teleflex now thrives as a diversified global provider of medical technologies designed to improve health and the quality of people's lives. It specializes in critical care and surgical solutions, focusing its efforts on areas like vascular access, anesthesia, respiratory care, and urology, among others. Teleflex Inc. crafts its financial landscape through a robust combination of product innovation, strategic acquisitions, and a strong global footprint. Their revenue streams are primarily derived from selling medical devices and equipment to healthcare providers worldwide. A significant competitive edge lies in its ability to consistently introduce new products that address unmet clinical needs while enhancing patient safety and outcomes. This focus is evident in their Research and Development initiatives, which are integral to maintaining their market position. Moreover, by acquiring companies with complementary technologies and market reach, Teleflex continually broadens its portfolio, navigating the complex and evolving healthcare landscape with finesse and agility. Through these strategic maneuvers, the company ensures a steady flow of revenue that aligns with global healthcare trends and demands.

TFX Intrinsic Value
276.36 USD
Undervaluation 35%
Intrinsic Value
Price

See Also

What is Teleflex Inc's Free Cash Flow?
Free Cash Flow
450m USD

Based on the financial report for Sep 29, 2024, Teleflex Inc's Free Cash Flow amounts to 450m USD.

What is Teleflex Inc's Free Cash Flow growth rate?
Free Cash Flow CAGR 10Y
6%

Over the last year, the Free Cash Flow growth was 19%. The average annual Free Cash Flow growth rates for Teleflex Inc have been -7% over the past three years , 7% over the past five years , and 6% over the past ten years .

Back to Top